Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Orit Gutfeld
27 years of experience
Clinic is certified :
Tongue cancer treatment cost in Israel typically involves a PET-CT scan ranging from $1,300 to $1,800 and essential follow-up procedures. Total expenses depend on the tumor stage, the necessity of complex reconstructive surgery, and whether the facility is public or private. High-quality care for this condition is primarily centered in Tel Aviv, Jerusalem, and Haifa.
Typical Tongue Cancer Treatment Costs in Israel
Bookimed Expert Insight: Patients requiring complex head and neck interventions benefit from the multidisciplinary approach at Sourasky Medical Center, which reports a 90% oncology success rate. For those prioritizing choice flexibility, Assuta Medical Center offers private surgical tracks with JCI-accredited standards. Advanced cases often require specialized teams; Hadassah Medical Center provides access to Forbes-listed specialists and extensive surgical expertise for rare oncological conditions.
| Israel | Turkey | Austria | |
| Tongue cancer surgery | from $28,500 | from $9,000 | from $35,000 |
| Partial Glossectomy | - | from $5,500 | - |
| Halcyon | - | from $5,400 | - |
Prof. Nadir Arber is a leading cancer prevention specialist and researcher, focusing on early detection methods. He heads the Integrated Cancer Prevention Center at Sourasky Medical Center.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Dr. Orit Gutfeld is a leading specialist for malignant tumors of the head and neck, with over 27 years of experience of clinical experience in oncology.
Professor Dan Fliss is a leading head and neck surgical oncologist at Sourasky Medical Center.
Primary tongue cancer treatment in Israel involves multidisciplinary protocols focused on tumor eradication and function preservation. Surgeons prioritize transoral robotic surgery using the da Vinci system for precision. Advanced radiation therapies like IMRT and specialized reconstructive microsurgery ensure patients maintain speech and swallowing capabilities.
Bookimed Expert Insight: Israeli oncology centers like Sheba Medical Center and Sourasky Medical Center report high success rates because they integrate robotic surgery with immediate rehabilitation. Data shows Sheba manages over 45,000 annual operations while Sourasky maintains a 90% oncology success rate. This high volume allows surgeons to master reconstructive techniques that significantly improve post-surgical speech quality.
Patient Consensus: Patients emphasize starting speech and swallowing therapy before surgery begins. They note that choosing centers with multidisciplinary teams, including specialized dentists, helps reduce long-term side effects like dry mouth.
Tongue cancer surgery in Israel temporarily impacts speaking and swallowing. Most patients see significant improvement within 12 weeks as swelling subsides. Success depends on the tumor size and surgical technique. Specialists use partial glossectomy to preserve tissue and maximize long-term oral function.
Bookimed Expert Insight: Israeli oncology centers like Sourasky or Sheba prioritize precision to maintain quality of life. Surgeons such as Prof. Dan Fliss specialize in maxillofacial oncology to ensure speech preservation. Data shows that institutions performing over 34,000 annual operations have higher success with complex reconstructions. These facilities often combine surgery with advanced genomic mapping to limit tissue removal.
Patient Consensus: Patients note that while the first month is physically challenging, swallowing usually recovers faster than speech clarity. Many emphasize that starting professional speech therapy immediately is essential for the best long-term results.
Major Israeli medical centers report an average 90% success rate for oncology treatments. Early-stage tongue cancer patients achieve 5-year survival rates between 83% and 90%. Success for advanced cases depends on lymph node involvement and prompt surgical intervention at multidisciplinary centers.
Bookimed Expert Insight: While Sheba Medical Center ranks among the top 10 hospitals globally, Sourasky Medical Center serves over 400,000 patients with a consistent 90% oncology success rate. Patients seeking the highest success should prioritize clinics that integrate robotic surgery with precision radiotherapy, as these technologies are standard at JCI-accredited Israeli centers.
Patient Consensus: Patients note that early detection is the most critical factor for a positive outcome. They emphasize discussing functional results, such as speech and swallowing preserved during surgery, rather than just survival statistics.
Sourasky Medical Center and Sheba Medical Center are the top Israeli hospitals for tongue cancer treatment. These JCI-accredited facilities offer advanced glossectomy and microvascular reconstruction to preserve speech. They provide specialized multidisciplinary care involving ENT surgeons and oncologists within high-volume oncology departments.
Bookimed Expert Insight: Data shows a clear distinction between public centers like Sheba and private facilities like Assuta. Sheba serves over 1,900,000 patients annually and leads in complex immunotherapies. Assuta specializes in shorter waiting times for surgery. Choosing Assuta may be faster if you need immediate surgical intervention by a specific professor.
Patient Consensus: Patients often mention the professionalism of the medical teams. They note that having all diagnostic tests completed in one building saves significant time during stressful treatment weeks.
Tongue cancer treatment in Israel typically requires a stay of 14 to 28 days. This window covers advanced diagnostics, surgery, and critical early recovery. Major centers like Sourasky or Sheba often discharge surgical patients within 7 days. Local follow-up care continues for another 2 weeks.
Bookimed Expert Insight: Israeli medical centers like Sheba and Sourasky operate at massive scales, with Sheba serving 2 million patients yearly. This high volume means their oncology teams see complex head and neck cases daily. Patients should check if their surgeon, such as Dr. Dan Fliss, is among the Forbes Best Doctors list. These highly-rated specialists often streamline the 7-day inpatient transition to outpatient care through advanced robotic techniques.
Patient Consensus: Patients note it is helpful to stay near the hospital in Tel Aviv or Ramat Gan after discharge. They emphasize that while the surgical stay is short, having a local base for the first 14 days is vital for follow-up speech and swallowing checks.